Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-28 Sale |
2023-02-27 9:15 pm |
CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner |
25,608 | $3.3552 | $85,920 | 0 (Indirect Direct) |
View |
| 2022-06-10 Sale |
2023-02-27 5:10 pm |
CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer |
40,006 | $0.00228 | $91 | 0 (Indirect Direct) |
View |
| 2023-02-24 Sale |
2023-02-24 6:38 pm |
CinCor Pharma Inc. | CINC | Kalb Michael Wayne EVP & Chief Financial Officer |
202,437 | $0 | $0 | 0 (Direct) |
View |
| 2023-02-24 Sale |
2023-02-24 6:36 pm |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
15,000 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-02-24 Sale |
2023-02-24 6:34 pm |
CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer |
200,000 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-15 Purchase |
2022-08-17 8:01 pm |
CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 10% Owner |
600,000 | $30 | $18,000,000 | 983,656 (Indirect) |
View |
| 2022-08-15 Purchase |
2022-08-17 4:19 pm |
CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner |
133,333 | $30 | $3,999,990 | 4,220,979 (Indirect) |
View |
| 2022-08-11 Purchase |
2022-08-15 3:46 pm |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner |
500,000 | $30 | $15,000,000 | 6,073,949 (Indirect) |
View |
| 2022-08-11 Purchase |
2022-08-15 3:45 pm |
CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner |
506,000 | $30 | $15,180,000 | 35,411 (Indirect Direct) |
View |
| 2022-08-11 Purchase |
2022-08-15 2:22 pm |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC GENPAR (BERMUDA) L.P. GAP (Bermuda) L.P. GAP Coinvestments CDA L.P. General Atlantic (CIN) L.P. General Atlantic (SPV) GP LLC 10% Owner |
83,000 | $30 | $2,490,000 | 4,209,470 (Indirect) |
View |
| 2022-08-11 Purchase |
2022-08-15 2:21 pm |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp 10% Owner |
83,000 | $30 | $2,490,000 | 4,209,470 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 9:32 pm |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC GENPAR (BERMUDA) L.P. GAP (Bermuda) L.P. GAP Coinvestments CDA L.P. General Atlantic (CIN) L.P. General Atlantic (SPV) GP LLC 10% Owner |
1,700,000 | $16 | $27,200,000 | 4,126,470 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 9:32 pm |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp 10% Owner |
1,700,000 | $16 | $27,200,000 | 4,126,470 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:45 pm |
CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner |
470,000 | $16 | $7,520,000 | 496,323 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:38 pm |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner |
325,000 | $16 | $5,200,000 | 5,573,949 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:36 pm |
CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner |
220,000 | $16 | $3,520,000 | 4,087,646 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:33 pm |
CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner |
325,000 | $16 | $5,200,000 | 5,573,949 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:31 pm |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
2,250 | $16 | $36,000 | 132,411 (Indirect Direct) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:28 pm |
CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development |
2,600 | $16 | $41,600 | 2,600 (Indirect Direct) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:26 pm |
CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer |
12,500 | $16 | $200,000 | 12,500 (Direct) |
View |
| 2022-01-11 Purchase |
2022-01-13 4:24 pm |
CinCor Pharma Inc. | CINC | Coelho Mary Theresa EVP CFO & Chief BD Officer |
100 | $16 | $1,600 | 100 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-24 Equity Swap |
2023-02-28 4:29 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner |
4,937,646 | $0 | 0 (Indirect) |
View |
| 2023-02-24 Equity Swap |
2023-02-27 9:15 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner |
6,083,752 | $0 | 0 (Direct) |
View |
| 2023-02-24 Equity Swap |
2023-02-27 5:10 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer |
2,594 | $0 | 0 (Direct) |
View |
| 2023-02-24 Equity Swap |
2023-02-24 6:36 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
141,649 | $0 | 0 (Direct) |
View |
| 2023-02-24 Equity Swap |
2023-02-24 6:34 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer |
12,500 | $0 | 0 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 8:08 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer |
200,000 | $0 | 212,500 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 8:07 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
15,000 | $0 | 156,649 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 8:04 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Kalb Michael Wayne EVP & Chief Financial Officer |
177,000 | $0 | 202,437 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 8:03 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer |
40,000 | $0 | 42,600 (Direct) |
View |
| 2023-01-11 Tax Withholding |
2023-01-19 4:34 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
3,997 | $28.75 | 154,885 (Direct) |
View |
| 2023-01-11 Exercise |
2023-01-19 4:34 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer |
13,235 | $0 | 154,885 (Direct) |
View |
| 2023-01-06 Option Award |
2023-01-10 4:18 pm |
2023-01-06 2033-01-05 |
CinCor Pharma Inc. | CINC | Allison David D. Director |
1,499 | $8.34 | 1,499 (Direct) |
View |
| 2022-11-04 Option Award |
2022-11-08 5:08 pm |
N/A 2032-11-03 |
CinCor Pharma Inc. | CINC | Kalb Michael Wayne EVP & Chief Financial Officer |
103,052 | $0 | 103,052 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 4:28 pm |
2022-10-07 2032-10-06 |
CinCor Pharma Inc. | CINC | Allison David D. Director |
524 | $23.85 | 524 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-08 12:57 pm |
N/A 2031-12-09 |
CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner |
29,411 | $0 | 5,603,360 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-08 12:57 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner |
29,411 | $13.6 | 5,603,360 (Direct) |
View |
| 2022-07-08 Option Award |
2022-07-20 4:44 pm |
2022-07-08 2032-07-07 |
CinCor Pharma Inc. | CINC | Allison David D. Director |
881 | $14.19 | 881 (Direct) |
View |
| 2022-04-08 Option Award(A) |
2022-07-20 4:39 pm |
2022-04-08 2032-04-07 |
CinCor Pharma Inc. | CINC | Allison David D. Director |
1,038 | $12.04 | 1,038 (Direct) |
View |
| 2022-04-08 Option Award |
2022-05-11 7:34 pm |
N/A 2032-04-07 |
CinCor Pharma Inc. | CINC | Allison David D. Director |
1,038 | $0 | 1,038 (Direct) |
View |
| 2022-01-11 Conversion |
2022-01-13 9:32 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC GENPAR (BERMUDA) L.P. GAP (Bermuda) L.P. GAP Coinvestments CDA L.P. General Atlantic (CIN) L.P. General Atlantic (SPV) GP LLC 10% Owner |
10,676,470 | $0 | 4,126,470 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-13 9:32 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp 10% Owner |
10,676,470 | $0 | 4,126,470 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:45 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner |
17,017,645 | $0 | 496,323 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:40 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | CinRx Pharma LLC 10% Owner |
5,379,135 | $0 | 3,630,103 (Direct) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:38 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner |
23,095,377 | $0 | 5,573,949 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:36 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner |
17,017,645 | $0 | 4,087,646 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:33 pm |
N/A N/A |
CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner |
23,095,377 | $0 | 5,573,949 (Indirect) |
View |